Product Information
THIAMINE 200 MG/2 ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $2.2468 per ML under NDC 63323001302. Its NADAC has been published 160 times since Jun 17, 2015.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AP.
Strength
100 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323001302
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
THIAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA080556FDA Approved
Before 1982
TE Code
AP
On Market Since
9/1/2000
Price Statistics
The NADAC for THIAMINE 200 MG/2 ML VIAL has been published 160 times since Jun 17, 2015, and over the history we have for it it has declined 43.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2468 per ML |
|---|---|
| All-time high | $3.9758 (Jun 15, 2016) |
| All-time low | $2.1624 (Aug 19, 2026) |
| 52-week high | $3.0083 |
| 52-week low | $2.1624 |
| Median price | $2.7314 |
| Average price | $3.0873 |
| Largest weekly change | -33.0% (Sep 18, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 17, 2015 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Fresenius Kabi USA, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
THIAMINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of THIAMINE 200 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for THIAMINE 200 MG/2 ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $2.2468 per ML (NDC 63323001302), effective Sep 30, 2026.
How has the price of THIAMINE 200 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for THIAMINE 200 MG/2 ML VIAL has declined 43.5%. It has been tracked across 160 weekly CMS publications since Jun 17, 2015.
What are the highest and lowest recorded NADAC prices for THIAMINE 200 MG/2 ML VIAL?
Since Jun 17, 2015, the NADAC for THIAMINE 200 MG/2 ML VIAL has ranged from a low of $2.1624 (Aug 19, 2026) to a high of $3.9758 (Jun 15, 2016), with a median of $2.7314 per ML.
Are there cheaper alternatives to THIAMINE 200 MG/2 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as THIAMINE 200 MG/2 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures THIAMINE 200 MG/2 ML VIAL?
THIAMINE 200 MG/2 ML VIAL (NDC 63323001302) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.